Literature DB >> 2459907

Tumor necrosis factor induces acute phase proteins in rats.

I Gresser1, F Delers, N Tran Quangs, S Marion, R Engler, C Maury, C Soria, J Soria, W Fiers, J Tavernier.   

Abstract

Inoculation of WAG rats with recombinant mouse tumor necrosis factor results in a rapid and marked increase in several acute phase proteins in the serum (haptoglobin, alpha 1 acid glycoprotein, alpha 2 macroglobulin) and in the plasma (fibrinogen). We conclude that TNF may play an important role in the inflammatory response in vivo and possibly in the pathogenesis of inflammatory disorders.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2459907

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN： 0393-974X            Impact factor:   1.711


  13 in total

1.  Talc granulomatosis in the rat. Involvement of bone in the acute-phase response.

Authors:  A Marusić; K Kos; A Stavljenić; S Vukicević
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

Review 2.  Hepatic acute phase reaction in vivo and in vitro.

Authors:  H Baumann
Journal:  In Vitro Cell Dev Biol       Date:  1989-02

3.  Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP).

Authors:  J A Barnett; D E Brenner; P J Creaven; D Lalka
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

4.  Why measure C reactive protein?

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 5.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

6.  An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease.

Authors:  N Foley; C Lambert; M McNicol; N Johnson; G A Rook
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

7.  High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.

Authors:  Ondrej Fiala; Milos Pesek; Jindrich Finek; Ondrej Topolcan; Jaroslav Racek; Marek Minarik; Lucie Benesova; Zbynek Bortlicek; Alexandr Poprach; Tomas Buchler
Journal:  Tumour Biol       Date:  2015-06-19

8.  Expression of C-reactive protein in the human respiratory tract.

Authors:  J M Gould; J N Weiser
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays.

Authors:  Kevin T Cwach; Heather R Sandbulte; Joshua M Klonoski; Victor C Huber
Journal:  Influenza Other Respir Viruses       Date:  2011-08-29       Impact factor: 4.380

10.  In vivo changes in plasma acute phase protein levels in the rat induced by slow release of IL-1, IL-6 and TNF.

Authors:  E J Lewis; A D Sedgwick; T H Hanahoe
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.